Komori
Rohto Pharmaceutical (4527) · RiskWorsened

Worsening Labor Shortages

First written in FY2018-Q1. 9 of 18 entries say "Restated". Latest entry: FY2026.

18entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2019-Q1RestatedFY2020-Q2 – FY2021RestatedFY2024-Q1 – FY2024-Q32017: 220172018: 220182019: 120192020: 320202021: 220212022: 320222023: 320232024: 120242025: 020252026: 12026
Same theme, other companies
Talent acquisition, development and retention, and labor compliance risksA theme 847 companies write about · 866 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 25 of 107 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 866 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「However, due to the declining birthrate and aging population, increased labor market mobility and intensifying competition to acquire talent, the Company may be unable to secure and develop the personnel required for research and development, manufacturing, quality assurance, overseas operations, digital operations and other areas as planned.」

    The company has clarified the previous concern over labour shortages as a risk of securing and developing personnel in research and development, manufacturing, quality assurance, overseas operations and digital operations.
  2. FY2024-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to the business and other risks described in the previous fiscal year, including the worsening labour shortage.
  3. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to the business and other risks described in the previous fiscal year, including the worsening labour shortage.
  4. FY2023MitigatedAnnual report

    「Segment profit (on an operating profit basis) increased substantially to ¥724 million, up 234.6% year on year, due to the efficient use of selling, general and administrative expenses despite a deterioration in the cost ratio caused by higher procurement costs for raw materials and higher labor costs due to labor shortages.」

    Higher labour costs and the deterioration in the cost ratio caused by the labour shortage continued, but the efficient use of selling, general and administrative expenses resulted in a 234.6% year-on-year increase in U.S. segment profit, limiting the impact on profit.
  5. FY2023-Q3MitigatedAnnual report

    「Segment profit, on an operating profit basis, was ¥327 million, up 155.2% year on year, as the cost ratio deteriorated due to higher procurement costs for raw materials and higher labor costs resulting from the labor shortage, but selling, general and administrative expenses were used efficiently.」

    Higher labour costs and the deterioration in the cost ratio caused by the labour shortage continued, but the efficient use of selling, general and administrative expenses resulted in a 155.2% year-on-year increase in U.S. segment profit, limiting the impact on profit.
  6. FY2023-Q2MaterialisedAnnual report

    「Segment profit, on an operating profit basis, decreased 34.6% year on year to ¥96 million due to higher procurement costs for raw materials, higher labor costs resulting from the labor shortage, and the impact of amortization of customer-related assets and goodwill of Hydrox Laboratories.」

    The labour shortage actually affected costs and profit in the United States through higher labour costs, and segment profit fell 34.6% year on year.
  7. FY2023-Q1MaterialisedAnnual report

    「Although higher procurement costs for raw materials and supplies, rising transportation costs and higher factory labour costs due to the labour shortage contributed to the deterioration in the cost ratio, increased operating rates and product price revisions, among other measures, resulted in higher profit of ¥135 million, up 26.9% year on year.」

    The labour shortage is reflected in actual profit factors through higher factory labour costs and a deterioration in the cost ratio.
  8. FY2022-Q3MaterialisedAnnual report

    「Segment profit, on an operating profit basis, was ¥162 million, down 4.3% year on year, as the cost ratio deteriorated due to higher procurement costs for raw materials and supplies, as well as the impact of the labor shortage.」

    The labour shortage, which was no longer presented as a standalone item in FY2021, is again described as having an actual impact in the United States, contributing to a deterioration in the cost ratio and a decline in segment profit.
  9. FY2021DroppedAnnual report
    In FY2021, the worsening labour shortage was not presented as a standalone risk item under “Business and Other Risks.”
  10. FY2021-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to business and other risks concerning the worsening labour shortage.
  11. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to business and other risks concerning the worsening labour shortage.
  12. FY2021-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to business and other risks concerning the worsening labour shortage.
  13. FY2020-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to business and other risks concerning the worsening labour shortage.
  14. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes to business and other risks concerning the worsening labour shortage.
  15. FY2019-Q1WorsenedAnnual report

    「In addition to rising raw material costs due to higher crude oil prices and rising labor costs due to the labor shortage, global trade tensions were a concern, and conditions remained uncertain.」

    In addition to the previous concern over a worsening labour shortage, the company now describes it as a factor accompanied by rising labour costs.
  16. FY2018-Q3RestatedAnnual report

    「On the other hand, concerns including worsening labor shortages, unstable policymaking by the US administration and geopolitical risks related to the situation on the Korean Peninsula contributed to continued uncertainty about the outlook.」

    The company has reconfirmed the worsening labour shortage as an outlook concern alongside political and geopolitical risks overseas.
  17. FY2018-Q2RestatedAnnual report

    「Meanwhile, concerns including the worsening labour shortage, overseas political risks and economic trends in emerging markets persisted, and the outlook remained uncertain.」

    The company has reconfirmed the worsening labour shortage as a concern in an uncertain economic environment.
  18. FY2018-Q1First statedAnnual report

    「Concerns including the worsening labour shortage, political risks overseas and economic trends in emerging markets have created continued uncertainty about the outlook.」

    The worsening labour shortage was identified for the first time as a standalone theme and a concern in an uncertain economic environment.
Moved together

"Risk of Higher Raw-Material Costs Due to Rising Crude Oil Prices" moved the same way as this thread, in the same document, in 4 of its 18 moves.

444332★123456
  1. ★This thread
  2. 1Risk of Higher Raw-Material Costs Due to Rising Crude Oil Prices4×
  3. 2Risk of declines in the value of partners and investees4×
  4. 3Collection Risk for Trade Receivables and Loans4×
  5. 4Political, Economic and Legal/Regulatory Risks Overseas3×
  6. 5Risk From Fluctuations in Foreign Exchange Rates, Share Prices and Interest Rates3×
  7. 6Technological Innovation and Strengthening the R&D Platform2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Rohto Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.